| Entry |
|
|---|
| Name |
Ozagrel (INN);
Cataclot (TN) |
|---|
| Formula |
C13H12N2O2
|
|---|
| Exact mass |
228.0899
|
|---|
| Mol weight |
228.25
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01516 Thromboxane A2 synthase inhibitor
|
|---|
| Remark |
| Product (DG01256): | D01683<JP> D01684<JP> |
|
|---|
| Efficacy |
Anticoagulant, Platelet aggregation inhibitor, Thromboxane A2 (TXA2) synthase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01516 Thromboxane A2 synthase inhibitor
DG01256 Ozagrel
D08327 Ozagrel
Target-based classification of drugs [BR:br08310]
Enzymes
Isomerases (EC5)
Thromboxane-A synthase
TBXAS1 (CYP5A1)
D08327 Ozagrel (INN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01516 Thromboxane A2 synthase inhibitor
DG01256 Ozagrel
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 N4y N 27.8600 -16.5200
2 C8x C 28.2800 -17.8500
3 C8x C 28.9800 -15.6800
4 C1b C 26.6000 -15.8900
5 N5x N 29.6800 -17.8500
6 C8x C 30.1000 -16.5200
7 C8y C 25.4100 -16.5900
8 C8x C 25.4100 -17.9900
9 C8x C 24.1500 -15.8900
10 C8x C 24.2200 -18.6900
11 C8x C 23.0300 -16.5900
12 C8y C 23.0300 -17.9900
13 C2b C 21.8400 -18.7600
14 C2b C 20.6500 -18.0600
15 C6a C 19.3900 -18.7600
16 O6a O 18.2000 -18.0600
17 O6a O 19.3900 -20.1600
BOND 18
1 2 5 2
2 3 6 2
3 4 7 1
4 7 8 2
5 7 9 1
6 8 10 1
7 9 11 2
8 10 12 2
9 12 13 1
10 5 6 1
11 11 12 1
12 13 14 2
13 14 15 1
14 1 2 1
15 15 16 1
16 1 3 1
17 15 17 2
18 1 4 1
|
|---|
